In 2022, the U.S. interventional cardiology device market size was valued at approximately $3.9 billion in 2022. Over the forecast, the market size is expected to increase to reach $4.8 billion by 2029.

The full report suite on the U.S. market for interventional cardiology devices includes coronary stents, coronary balloon catheters, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices (EPD), coronary atherectomy and intravascular lithotripsy devices, coronary thrombectomy devices, coronary chronic total occlusion (CTO) systems, introducer sheaths, coronary vascular closure devices (VCD), diagnostic coronary catheters and guidewires, coronary intravascular ultrasound (IVUS), coronary optical coherence tomography (OCT) and hemostasis valves.

Throughout this medical market research, we analyzed 43 interventional cardiology device companies across the United States and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Procedure Volumes for the Interventional Cardiology Devices
• Market Forecasts Until 2029, and Historical Data to 2019
• Competitive Analysis with Market Shares for Each Segment
• Market Drivers & Limiters for Each Interventional Cardiology Device Market
• Recent Mergers & Acquisitions
• COVID19 Impact on the Interventional Cardiology Device Market in the US
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

PROCEDURE NUMBERS

Coronary artery disease (CAD) is a multifaceted disease that yields various approaches in terms of diagnosis and treatment options. The most commonly performed procedure within the interventional cardiology space is angiography. Angiography remains the gold standard for diagnostic coronary procedures. This report also analyzes angioplasty (or PCI) procedures, Coronary Total Occlusion (CTO) and coronary atherectomy procedures.

U.S. Interventional Cardiology Market Insights

Demographics are still playing a positive role in the market as the population both ages and increases in size. According to the American Heart Association, about 6.7% of all American adults have cardiac artery disease (CAD). Because cardiovascular disease tends to be much more prevalent as a person ages, these two factors are contributing to an overall increase in procedure numbers and potential patients.

U.S. Interventional Cardiology Market Share Insights

The U.S. Interventional Cardiology device market was controlled by Boston Scientific, Abbott, and Medtronic.

Boston Scientific is an extremely well-established competitor in the interventional cardiology field, with a strong reputation and large sales force in both the coronary and peripheral markets. The company has recently emphasized its focus on the complex Percutaneous Coronary Intervention (PCI) opportunity in the market, for which it offers specialized devices, such as CTO systems, atherectomy devices, specialty balloon catheters, embolic protection devices, IVUS and Fractional Flow Reserve (FFR).

Detailed Market Segmentation

• Coronary Stent Market – MedCore – The market is further broken down into segments by:
  • Device Type: Bare-Metal Stents, Drug-Eluting Stents, Covered Stents, and Bifurcated Stents;
  • Units Size: Length and Diameter.
• Coronary Balloon Catheter Market – MedCore – The market is also further segmented by:
  • Device Type: PTCA Balloon and Specialty Balloon (Cutting/Scoring);
  • Classification: Compliant, Semi-Compliant, and Non-Compliant;
  • Indication: Pre-Dilation & Stent Placement, and Post-Dilation.
• Introducer Sheath Market – MedCore – The chapter contains the market analysis which  is categorized by:
  • Device Type: Standard Introducer and Micro-Introducer Sheaths;
  • Approach:  Femoral and Radial.
• Balloon-Inflation Device Market – MedCore – In-depth analysis of the Balloon-Inflation Device market.
• Interventional Coronary Catheter Market – MedCore – This market and its analysis is categorized into Guiding Catheters, Extension Guide Catheters, and Micro-Catheters.
• Interventional Coronary Guidewire Market – MedCore – In-depth analysis of the Interventional Coronary Guidewire market.
• Coronary Embolic Protection Device Market – MedCore – In-depth analysis of the Coronary Embolic Protection Device market.
• Coronary Atherectomy Device Market – MedCore – The market is further broken down into Mechanical Atherectomy and Laser Atherectomy devices.
• Coronary Thrombectomy Market – MedCore – In-depth analysis of the Coronary Thrombectomy market.
• Coronary Chronic Total Occlusion (CTO) System Market – MedCore – This market consists of the segments for the CTO Guidewires, CTO Catheters, and CTO Devices.
• Coronary Vascular Closure Device (VCD)  Market – MedCore – The market analysis includes the segments, such as Invasive and Non-Invasive VCDs (Topical Hemostats/Radial Compression Bands/Femoral Compression Bands).
• Diagnostic Coronary Catheter & Guidewire Market – MedCore – The chapter takes a closer look at the different market segments, including Diagnostic Catheter, Diagnostic Guidewire, and FFR Guidewire markets.
• Coronary Intravascular Ultrasound (IVUS) Market – MedCore – The market is further broken down into segments based on the Device Type into IVUS Catheters and  IVUS Consoles.
• Coronary Optical Coherency Tomography Market – MedCore – In-depth analysis of the Coronary Optical Coherency Tomography market.
• Hemostasis Valve Market – MedCore – In-depth analysis of the Hemostasis Valve market.

 RESEARCH SCOPE SUMMARY

\WHY CHOOSE IDATA?

• Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
• Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
• Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
• Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

FREE Sample Report